Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis

BACKGROUND: The efficacy and safety of rituximab (RTX) on hemolytic anemia (HA) is unknown. Therefore we retrospectively analyze the efficacy and safety of RTX in autoimmune hemolytic anemia (AIHA) and microangiopathic hemolytic anemia (MAHA) from the previous literature. METHODS: Data in clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Shih-Hsuan, Chang, Yuh-Lih, Yen, Jiin-Cherng, Liao, Hsien-Tzung, Wu, Tsai-Hung, Yu, Chia-Li, Tsai, Chang-Youh, Chou, Yueh-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161265/
https://www.ncbi.nlm.nih.gov/pubmed/32322437
http://dx.doi.org/10.1186/s40164-020-00163-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161265/
https://www.ncbi.nlm.nih.gov/pubmed/32322437
http://dx.doi.org/10.1186/s40164-020-00163-5

Ejemplares similares